首頁 > 市場調查報告書 > 醫療設備

體外診斷

歐洲凝血市場預測至 2030 年 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

市場調查報告書

商品編碼

1494295

歐洲凝血市場預測至 2030 年 - 區域分析 - 按疾病適應症、類型、產品、技術和最終用戶

Europe Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 116 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲凝血市場價值為200064萬美元，預計2030年將達337971萬美元；預計2022年至2030年複合年成長率為6.8%。

心血管疾病盛行率上升推動歐洲凝血市場

心臟病是心房顫動和中風等疾病導致住院、死亡和身體機能下降的主要原因之一。它影響止血系統、血管系統和血液的流體動力學，並導致動脈和靜脈血栓形成。血栓形成是心血管疾病死亡和併發症的主要原因。因吸菸和高血壓而受損的血管會在血管內壁形成富含膽固醇的斑塊，這些斑塊會破裂並導致血小板凝結。凝血障礙有心肌梗塞、中風和血管床動脈粥狀硬化血栓事件的風險。心臟衰竭（HF）與血栓栓塞風險增加有關，與心房顫動（AF）的存在無關。血小板活化和凝血系統異常會增加心臟衰竭患者發生嚴重血栓栓塞事件的風險。

凝血測試有助於預防潛在的心臟病發作引起的血液凝固。在冠狀動脈繞道手術和血管成形術期間使用凝血分析儀來監測凝血狀態的資訊。因此，心血管疾病發生率的上升促進了凝血市場的成長。

歐洲混凝市場概況

歐洲凝血市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。歐洲在全球凝血市場中佔有重要地位，預計 2022 年至 2030 年複合年成長率將強勁。該地區的市場成長主要歸因於心血管疾病發病率的上升、醫療設備的不斷進步、人口老化的加劇以及凝血分析儀意識的提高。

德國有很多人患有心血管疾病，這可歸因於該國人口老化的加劇。心臟病發作是冠狀動脈心臟病（CHD）最嚴重的後果。迄今為止，超過 360 萬德國人被診斷出患有先心病，超過 130 萬名中風患者存活。根據世界衛生組織2020年公佈的最新資料，德國因冠心病導致的死亡人數達147,055人（佔總死亡人數的20.98%）。

歐洲凝血市場收入及 2030 年預測（百萬美元）

歐洲混凝市場細分

歐洲凝血市場根據疾病適應症、類型、產品、技術、最終用戶和國家進行細分。

根據疾病適應症，歐洲凝血市場分為維生素 K 缺乏症、肝病、瀰漫性血管內凝血及肺栓塞、循環抗凝血劑的發展、血友病、馮維勒布蘭氏症等。 2022 年，肝病領域佔據歐洲凝血市場最大佔有率。

根據類型，歐洲凝血市場分為臨床實驗室分析儀和即時檢測分析儀。 2022 年，臨床實驗室分析儀細分市場將佔據更大的歐洲凝血市場佔有率。等。

在產品方面，歐洲凝血市場分為診斷和治療。至2022年，診斷細分市場將佔據更大的歐洲凝血市場佔有率。 D-二聚體測試、血小板功能測試等。治療部分進一步細分為抗纖溶藥物、避孕藥、去氨加壓素和免疫抑制藥物、維生素K 補充劑、血液稀釋劑、凝血酶抑制劑或血栓溶解劑、替代療法、導管輔助血栓清除等。

依技術分類，歐洲凝血市場分為光學技術、機械技術、電化學技術等。到 2022 年，光學技術領域將佔據歐洲凝血市場最大佔有率。

依最終用戶分類，歐洲凝血市場分為臨床實驗室、醫院等。到 2022 年，醫院細分市場將佔據歐洲最大的凝血市場。

根據國家/地區，歐洲凝固市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲凝固市場佔據主導地位。

F.霍夫曼-拉羅氏有限公司；根瑞生物科技有限公司；堀場有限公司； ImproGen Diagnostik Kimya San。＆抽動。有限公司；西門子醫療集團；希森美康公司；汎亞生物醫療有限公司；和 Nordic Biomarker AB 是歐洲凝血市場上的一些領先公司。

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

Europe Coagulation Market Overview

The Europe coagulation market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe holds a significant position in the global coagulation market and is estimated to register a robust CAGR during 2022-2030. Market growth in this region is mainly attributed to the rising incidence of cardiovascular disorders, increasing advancements in medical devices, the growing aging population, and the surging awareness of coagulation analyzers.

A large number of people in Germany are suffering from cardiovascular disorders, which can be attributed to the growing aging population in the country. Heart attack is the most serious consequence of coronary heart disease (CHD). More than 3.6 million of the German population have been diagnosed with CHD till date, and over 1.3 million have survived a stroke. According to the latest WHO data published in 2020, the count of deaths caused by CHD in Germany reached 147,055 (i.e., 20.98% of total deaths).

Europe Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Europe Coagulation Market Segmentation

The Europe coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Europe coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Europe coagulation market share in 2022.

Based on type, the Europe coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Europe coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Europe coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Europe coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Europe coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Europe coagulation market share in 2022.

By end user, the Europe coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Europe coagulation market share in 2022.

Based on country, the Europe coagulation market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.; Siemens Healthineers AG; Sysmex Corp; Transasia Bio-Medicals Ltd; and Nordic Biomarker AB are some of the leading companies operating in the Europe coagulation market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis

5. Coagulation Market - Europe Market Analysis

5.1 Europe Coagulation Market Revenue (US$ million), 2022 - 2030

6. Europe Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview
6.2 Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview
8.2 Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Europe Coagulation Market, by Diagnosis
8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Europe Coagulation Market, by Treatment

9. Europe Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview
9.2 Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Coagulation Market - Country Analysis

11.1 Europe Coagulation Market, Revenue and Forecast to 2030
- 11.1.1 Europe Coagulation Market by Country
  - 11.1.1.1 Germany
    - 11.1.1.1.1 Overview
    - 11.1.1.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.1.3 Germany Coagulation Market, by Disease Indication
    - 11.1.1.1.4 Germany Coagulation Market, by Type
    - 11.1.1.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.1.5 Germany Coagulation Market, by Offering
    - 11.1.1.1.5.1 Germany Coagulation Market, by Diagnosis
    - 11.1.1.1.5.2 Germany Coagulation Market, by Treatment
    - 11.1.1.1.6 Germany Coagulation Market, by Technology
    - 11.1.1.1.7 Germany Coagulation Market, by End User
  - 11.1.1.2 UK
    - 11.1.1.2.1 Overview
    - 11.1.1.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.2.2 UK Coagulation Market, by Disease Indication
    - 11.1.1.2.3 UK Coagulation Market, by Type
    - 11.1.1.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.2.4 UK Coagulation Market, by Offering
    - 11.1.1.2.4.1 UK Coagulation Market, by Diagnosis
    - 11.1.1.2.4.2 UK Coagulation Market, by Treatment
    - 11.1.1.2.5 UK Coagulation Market, by Technology
    - 11.1.1.2.6 UK Coagulation Market, by End User
  - 11.1.1.3 France
    - 11.1.1.3.1 Overview
    - 11.1.1.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.3.2 France Coagulation Market, by Disease Indication
    - 11.1.1.3.3 France Coagulation Market, by Type
    - 11.1.1.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.3.4 France Coagulation Market, by Offering
    - 11.1.1.3.4.1 France Coagulation Market, by Diagnosis
    - 11.1.1.3.4.2 France Coagulation Market, by Treatment
    - 11.1.1.3.5 France Coagulation Market, by Technology
    - 11.1.1.3.6 France Coagulation Market, by End User
  - 11.1.1.4 Italy
    - 11.1.1.4.1 Overview
    - 11.1.1.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.4.2 Italy Coagulation Market, by Disease Indication
    - 11.1.1.4.3 Italy Coagulation Market, by Type
    - 11.1.1.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.4.4 Italy Coagulation Market, by Offering
    - 11.1.1.4.4.1 Italy Coagulation Market, by Diagnosis
    - 11.1.1.4.4.2 Italy Coagulation Market, by Treatment
    - 11.1.1.4.5 Italy Coagulation Market, by Technology
    - 11.1.1.4.6 Italy Coagulation Market, by End User
  - 11.1.1.5 Spain
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.5.3 Spain Coagulation Market, by Disease Indication
    - 11.1.1.5.4 Spain Coagulation Market, by Type
    - 11.1.1.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.5.5 Spain Coagulation Market, by Offering
    - 11.1.1.5.5.1 Spain Coagulation Market, by Diagnosis
    - 11.1.1.5.5.2 Spain Coagulation Market, by Treatment
    - 11.1.1.5.6 Spain Coagulation Market, by Technology
    - 11.1.1.5.7 Spain Coagulation Market, by End User
  - 11.1.1.6 Rest of Europe
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.6.3 Rest of Europe Coagulation Market, by Disease Indication
    - 11.1.1.6.4 Rest of Europe Coagulation Market, by Type
    - 11.1.1.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
    - 11.1.1.6.5 Rest of Europe Coagulation Market, by Offering
    - 11.1.1.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
    - 11.1.1.6.5.2 Rest of Europe Coagulation Market, by Treatment
    - 11.1.1.6.6 Rest of Europe Coagulation Market, by Technology
    - 11.1.1.6.7 Rest of Europe Coagulation Market, by End User

12. Europe Coagulation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Nordic Biomarker AB
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sysmex Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Genrui Biotech Co., Ltd.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Transasia Bio-Medicals Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Horiba Ltd.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Coagulation Market Segmentation
Table 2. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 4. Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 8. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 9. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 10. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 11. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 12. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 13. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 14. Germany Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 15. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 16. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 17. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 18. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 19. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 20. UK Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 21. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 22. UK Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 23. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 24. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 25. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 26. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 27. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 28. France Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 29. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 30. France Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 31. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 32. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 34. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 35. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 36. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 37. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 38. Italy Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 39. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 40. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 41. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 42. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 43. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 44. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 45. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 46. Spain Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 47. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 48. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 49. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 50. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 51. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 52. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 53. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 54. Rest of Europe Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
Table 56. Recent Organic Growth Strategies in the Coagulation Market
Table 57. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Europe Coagulation Market Segmentation, By Country
Figure 2. Europe Coagulation Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 5. Europe Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand's Disease: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Europe Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 29. Europe Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. France Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 35. Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 36. Growth Strategies in the Coagulation Market